Ubs Group Ag In Med Pharmaceuticals Inc. Transaction History

Ubs Group Ag

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.32 - $0.44 $13 - $18	41 New	41 $0
Q3 2023 Nov 09, 2023	BUY	$0.69 - $1.22 $47 - $84	69 New	69 $0
Q1 2023 May 12, 2023	BUY	$1.05 - $2.3 $1,880 - $4,119	1,791 Added 215.52%	2,622 $2,000
Q4 2022 Feb 08, 2023	SELL	$1.32 - $7.95 $6,555 - $39,479	-4,966 Reduced 85.66%	831 $1,000
Q3 2022 Nov 10, 2022	BUY	$5.11 - $18.78 $29,622 - $108,867	5,797 New	5,797 $38,000

463K

Ticker INM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 908,761
Market Cap $218K
Description
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in precl...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.